ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166237; 2) Community: the network communities that were significantly associated with the response to NSC 166237; 3) Molecule: the relationships between components within communities and NSC 166237; 4) MDR: the compounds that were significantly associated with the NSC 166237.

NSC Compound Enrichment Correlation
NSC 93354 Null 0.00863223795880985 0.29312327
NSC 349174 Oxanthrazole 0.00896740831404549 0.51317254
NSC 615803 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2,2'-[1,2- ethanediylbis(imino-3,1-propanediyl)]bis[5,8-dinitro-, dihydrochloride 0.00896740831404549 0.33681441
NSC 646278 Pyrido[3',4':4,5]thieno[2,3-g]isoquinoline, 6-methyl- 0.00896740831404549 0.51307964
NSC 664529 Null 0.00896740831404549 0.20258562
NSC 678383 Benzoic acid, 2-[(4,6-dimethyl-1-oxo-2-indanylidene) methyl]-5-methyl-, methyl ester 0.00896740831404549 -0.11597743
NSC 681640 Camptothecin Derivative 0.00896740831404549 0.5262087
NSC 693117 Null 0.00896740831404549 0.46764867
NSC 733654 6-(3-Chloropropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.00896740831404549 0.42991537
NSC 632737 Tris(1,10-phenanthroline)lanthanum(III)-trithiocyanate 0.0090516764346157 0.2181245
Total:64  Current:18    [First] [Prev] [Next] [Last]